Searched for
NOVARTIS OTC
Dr Reddy's Laboratories launches over-the-counter eye allergy drop in USDr Reddy's said Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, are indicated for the temporary relief of...- Dr Reddy's launches generic arthritis drug in US market"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our con...
- GSK Consumer Healthcare appoints Filippo Lanzi as APAC headCommenting on the appointment, McNamara said: "His (Lanzi) people-focused leadership style and proven track record of growing categories an...
- Novartis India Q1 net at Rs 19 croreThe company had posted a net profit of Rs 13.34 crore for the corresponding period of the previous fiscal, Novartis India said in a filing ...
- Novartis slumps after Q4 numbers, buyback announcementCompany said its standalone total income from operations stood at Rs 167.27 cr for Q4, compared with Rs 207.64 cr in the corresponding peri...
- GSK Healthcare banks on Sensodyne, Crocin to drive growth in IndiaIn India, the power brands will be Sensodyne, Panadol (called Crocin in India), nasal decongestant Otrivin and Voltaren pain relieving gels...
- Novartis India Q3 net at Rs 60 croreNet sales during the period under review stood at Rs 183.38 crore while in the same period last fiscal it was at Rs 213.02 crore.
- Novartis India Q2 net rises over 600% to Rs 104 croreIn April, Novartis had agreed to divest its global Animal Health business to Lilly by transferring it to Elanco India or another affiliate ...
- Novartis India gets FIPB nod to sell OTC biz to GSK CPLNovartis India today said it has received FIPB approval to sell its OTC division to GlaxoSmithKline Consumer Pvt Ltd (GSK CPL).
- Novartis India Q1 net profit falls 6% to Rs 13.45 croreDrug firm Novartis India today reported six per cent fall in its standalone net profit at Rs 13.45 crore for the first quarter ended June 3...
- Novartis Q3 net loss at Rs 1.18 croreThe company had posted a net profit of Rs 15.23 crore in the same period last fiscal, Novartis India said in a filing to the Bombay Stock E...
- Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-croreNovartis's board approved sale of its OTC division to GSK Consumer Pvt Ltd, a consumer healthcare JV between Novartis AG & GSK, for a consi...
- GSK Consumer Healthcare Zubair Ahmed appointed head of Asia Pacific, Middle East and Africa regionAs part of the new role, Ahmed will oversee operations of over 100 countries, joining the growing league of Indians taking on top roles glo...
- Novartis India Q1 net profit up 3% at Rs 14.31 croreThe company had posted a net profit of Rs 13.87 crore for the corresponding period of the previous fiscal.
- Novartis India launches topical body pain relieverNovartis India's OTC division said it has launched topical body pain reliever Voltaren Emulgel in India.
- Dr Reddy's launches lansoprazole capsules in US marketThe company has launched over-the-counter lansoprazole delayed-release capsules in the US market on May 18.
- Novartis India Q3 net dips 5.30 pc to Rs 38.35 crThe company had posted a net profit of Rs 40.50 crore for the quarter ended December 31, 2010 Novartis India said in a filing to BSE.
- OTC drugs turn money spinnersFood supplement Revital has become Ranbaxy's top-selling product, the first time that an over-the-counter drug has occupied the slot for In...
- 'There's room for low-priced generics’Novartis has recognised the growth potential of rural India early on. ET caught up with Olivier Jarry, senior vice president (strategy and ...
- Post offices may soon sell medicinesPost offices may soon turn into pill posts as pharma majors are planning a pilot project to sell OTC drugs in UP, MP & Maharashtra.
Load More
